replacement available Recalls

B. Braun Medical IV Administration Set Recall for 1,250 Units Over Backflow Risk (2025)

Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).

B Braun Medical IV Administration Set Recall Affects 2,544 Units Worldwide

Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).

B. Braun Medical Recalls 12,320 IV Burette Sets Over Backflow Risk (2025)

Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).

B. Braun Medical Blood Administration Set Recall 33,528 Units for Backflow Risk (2025)

Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).

B. Braun Medical Extension Set 490234 Recalled for 27,480 Units Over IV Backflow Risk (2025)

Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).

B. Braun Medical 490238 Extension Set Recalled for IV Backflow Risk (2025)

Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).

B Braun Medical ADDitIV Sets Recalled for High Backflow and Occlusion Risk, 43,900 Units Worldwide

Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).

B. Braun Medical Rate Flow IV Set Recalled for 150,664 Units in 2025

Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).

B. Braun Medical IV Administration Sets Recalled for Backflow Risk — 1,861,111 Units (2025 Recall)

Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).

Philips Incisive CT Recall 2025: 2,341 CT Scanners Over Loose Tube Heat Exchanger Screws

B. Braun Medical Inc. IV Administration Set Recalled for Backflow and Priming Occlusion (490407)

Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).

B. Braun Medical IV Administration Set Recall Affects 286,400 Units Across Global Pumps (2025)

Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).

Medtronic Aurora EV-ICD Recall 2025: 6,591 Units Worldwide Recalled for Possible Delay in High-Volt­

There is a potential for delayed time to high-voltage (HV) therapy should a rare sequence of events occur.

BBMIs Infusomat IV Administration Set Recall, 63,192 Units Worldwide for Backflow and Occlusion Risk

Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).

Avion Pharmaceuticals Prenate Chewable Prenatal Vitamin Recalled for Undeclared Soy (804 Bottles, 5

Undeclared Soy. The firm received positive test results for soy which is not listed on the label. The firm also noticed that the amount of boron in the product is listed as 250mg per serving instead of 250mcg per serving.

B. Braun Medical IV Administration Set Recall 2025 for Backflow and Occlusion Risk (490437)

Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).

B. Braun Medical IV Administration Sets Recalled for Backflow and Occlusion Risk (490549, 490565)

Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).

B Braun Medical Recalls 19,104 IV Administration Sets for Backflow Risk (2025)

Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).

B. Braun Medical IV Administration Set Recall 122,232 Units Over Backflow Risk (2025)

Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).

B. Braun Medical Recalls 554,015 SafeDAY IV Sets Over Backflow Risk (2025)

Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).